This ad will auto close in 10 seconds

Drug developed for crop protection gets US patent

Last Updated: Monday, September 16, 2013 - 16:10

Ahmedabad: A drug developed by a Nagpur-based research and development institute from cow urine to provide protection to all crops against pests has received a US patent, a senior official said.

"The drug promotes growth of crops four times and fights all types of germs, virus and fungus. The drug has received a US patent," Go Vigyan Anusandhan Kendra (GVAK) chief co-ordinator Sunil Mansinghka told a news agency, on the sidelines of a conference here.

The drug, `Kamdhenu Kitniyantrak`, is a synergistic composition comprising cow urine, neem and garlic, individually or in various combinations. It also enhances immunity of the plants.

The drug is a soil health enhancer, which will help farmers move from chemical farming to non-chemical farming, the official said.

He claimed that this drug can reduce use of pesticides to the tune of Rs 50,000 crore.

It can be manufactured at homes in villages, thereby helping in rural transformation and employment generation, he said.

The drug has been developed by GVAK in collaboration with National Botanical Research Institute (NBRI), a Lucknow-based laboratory of Council of Scientific and Industrial Research (CSIR).

Apart from this patent, the Nagpur-based GVAK has received five more patents for developing an anti-cancer drug, extracted from cow urine for its anti-genotoxicity properties.

GVAK`s drug `Kamdhenu Ark` had previously got the US patent as a bio-enhancer with antibiotics and anti-cancer drugs.

Mansinghka said the organisation is also working on developing mosquito-repellent coils by using cow dung and various other herbs. In addition, research is also going on developing phenyl from cow urine, he said.

Established in 1996, GVAK is a registered research and development institution working on role of cow and its progeny in betterment of human life.


First Published: Monday, September 16, 2013 - 16:10

More from zeenews

comments powered by Disqus